Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Prego

Prego

posted on Feb 19, 2009 03:05PM

Personally, this is the best letter to date. IMO, it's put the flavor back in the MMP.

Can't put my finger on it but there's something about this letter that's got me once again excited about the 'sweeping scope' of the MMP. The letter was very unexpected (at least for me)...on the heels of the last letter, just 10 days ago. And even though it contained information perhaps already known (except for the company in Germany that filed the 'reexam counterpart'), hearing it in this context, gives me more confidence that I've had in a very long time.

Regards,
PxP

____________________________________...

While the action, initiated by Deutsche Telecom, to nullify the German patent was positive in the favor of our patent, the decision is expected to have no impact on the ultimate result of the USPTO re-examinations underway on four of the seven MMP™ patents.

To clarify, the German proceeding was the counterpart of the USPTO patent re-examination process.

We remain confident that the USPTO will re-affirm the strength of the MMP™ Portfolio whenever its final actions are determined and made public.







Share
New Message
Please login to post a reply